Anpario stock analysis
Anpario (KI9A) Stock Price & Analysis
KI9A Stock Chart & Stats
- Day’s Range
- EUR 5.80 - EUR 5.90
- 52-Week Range
- EUR 4.52 - EUR 7.00
- Previous Close
- EUR 6.00
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 101.00M
- Enterprise Value
- EUR 83.21M
- Total Cash (Recent Filing)
- EUR 10.96M
- Total Debt (Recent Filing)
- EUR 252.00K
- Price to Earnings (P/E)
- 12.4
- Beta
- 1.07
- Next Earnings
- Mar 17, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 2.41%
Bulls Say, Bears Say
Bulls Say
Very Low Leverage
An exceptionally conservative balance sheet reduces financial risk and preserves flexibility through changing trading conditions. Near-zero leverage limits interest and refinancing burdens, while the substantial equity base supports continued investment and gives management more options for funding growth.
Strong Revenue And Profit Growth
Multi-year revenue expansion alongside higher absolute profit indicates growing commercial scale and improving earnings power. Continued positive annual growth in 2025 suggests customer demand and market reach remain supportive, strengthening the company’s ability to reinvest and build operating resilience.
Positive Free Cash Flow
Strong recent free cash flow demonstrates that the business can convert operations into internally generated funds. This supports investment, dividends, and balance-sheet strength without relying heavily on borrowing, while the 2025 result provides a solid base for sustaining operations over coming quarters.
Bears Say
Margin Volatility
Margin performance has not been consistently maintained at earlier peak levels, indicating pressure on operating efficiency or profitability conversion over time. Even with improving absolute earnings, this volatility can make future profit growth less predictable and limit the durability of earnings expansion.
Uneven Cash Conversion
Although cash generation is generally healthy, periods of weak conversion show that reported earnings do not always translate promptly into available cash. Such variability can constrain funding for investment or shareholder returns in weaker periods and makes cash-based performance less dependable.
Modest Balance-sheet Fluctuations
The balance sheet remains exceptionally strong, but year-to-year movement in total assets and equity introduces some variability in the capital base. This is a limited concern rather than a major weakness, yet it reduces the consistency of the company’s underlying financial position across reporting periods.
Anpario News
KI9A FAQ
What was Anpario’s price range in the past 12 months?
What is Anpario’s market cap?
When is Anpario’s upcoming earnings report date?
How were Anpario’s earnings last quarter?
Is Anpario overvalued?
Does Anpario pay dividends?
What is Anpario’s EPS estimate?
How many shares outstanding does Anpario have?
What happened to Anpario’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Anpario?
What is the TipRanks Smart Score and how is it calculated?
Anpario Stock Smart Score
Company Description
Anpario
Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands. The company's hygiene and insect control category contain products comprising water sanitation tablets, 100% natural insect control powders, and natural drying agents that minimizes the environmental microbial burden, supports the gut health, and animal performance under the Credence, Mitex, and Clean & Dry brands; and toxin management category products consisting of mycotoxin binders under the Anpro brand. It has operations in the Americas, Asia, Europe, the Middle East, and Africa. The company was formerly known as Kiotech International plc and changed its name to Anpario plc in November 2011. Anpario plc was founded in 1996 and is headquartered in Worksop, the United Kingdom.
- Sector
- Consumerdefensive
- Industry
- Agricultural - Commodities/Milling
- CEO
- Richard Edwards
- Employees
- 162
- Website
- www.anpario.com
- Address
- Manton Wood Enterprise Park, Worksop, NT, S80 2RS, GB
Anpario (KI9A) Earnings & Revenues
KI9A Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 5 | 8 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 6 | 0 | 6 |









